126 related articles for article (PubMed ID: 2981447)
1. Antigenic conservation and divergence between the viral-specific proteins of poliovirus type 1 and various picornaviruses.
Emini EA; Schleif WA; Colonno RJ; Wimmer E
Virology; 1985 Jan; 140(1):13-20. PubMed ID: 2981447
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus.
Graham S; Wang EC; Jenkins O; Borysiewicz LK
J Virol; 1993 Mar; 67(3):1627-37. PubMed ID: 7679749
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of antigenic variation in the picornaviruses.
Brown F
Ann N Y Acad Sci; 1980; 354():202-18. PubMed ID: 6164329
[No Abstract] [Full Text] [Related]
4. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
Wiegers KJ; Dernick R
J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
[TBL] [Abstract][Full Text] [Related]
5. Cross antigenicity among enteroviruses as revealed by immunoblot technique.
Mertens T; Pika U; Eggers HJ
Virology; 1983 Sep; 129(2):431-42. PubMed ID: 6312682
[TBL] [Abstract][Full Text] [Related]
6. Antigenic comparison of the polypeptides of foot-and-mouth disease virus serotypes and other picornaviruses.
Grubman MJ; Zellner M; Wagner J
Virology; 1987 May; 158(1):133-40. PubMed ID: 2437694
[TBL] [Abstract][Full Text] [Related]
7. Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus.
Minor PD; Ferguson M; Phillips A; Magrath DI; Huovilainen A; Hovi T
J Gen Virol; 1987 Jul; 68 ( Pt 7)():1857-65. PubMed ID: 3037010
[TBL] [Abstract][Full Text] [Related]
8. Polyprotein processing in picornavirus replication.
Kräusslich HG; Nicklin MJ; Lee CK; Wimmer E
Biochimie; 1988 Jan; 70(1):119-30. PubMed ID: 2840974
[TBL] [Abstract][Full Text] [Related]
9. Antigenic specificity of poliovirus-related particles.
Ghendon YZ; Yakobson EA
J Virol; 1971 Oct; 8(4):589-90. PubMed ID: 4331656
[TBL] [Abstract][Full Text] [Related]
10. Antigenic structure of picornaviruses.
Minor PD
Curr Top Microbiol Immunol; 1990; 161():121-54. PubMed ID: 2169382
[No Abstract] [Full Text] [Related]
11. Location and primary structure of a major antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW
Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919
[TBL] [Abstract][Full Text] [Related]
12. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
13. Evidence for conformational changes of poliovirus precursor particles during virus morphogenesis.
Wiegers KJ; Dernick R
J Gen Virol; 1985 May; 66 ( Pt 5)():1037-44. PubMed ID: 2582079
[TBL] [Abstract][Full Text] [Related]
14. Isolation of antigenic mutants of type 1 poliovirus: growing the virus in the presence of homologous antiserum.
Hashimoto N
Jpn J Vet Res; 1980 Apr; 28(1-2):19-30. PubMed ID: 6251301
[No Abstract] [Full Text] [Related]
15. Antigenic and structural relatedness among non-capsid and capsid polypeptides of polioviruses belonging to different serotypes.
Romanova LI; Tolskaya EA; Agol VI
J Gen Virol; 1981 Feb; 52(Pt 2):279-89. PubMed ID: 6169783
[TBL] [Abstract][Full Text] [Related]
16. Determination of antigenic properties of vaccine derived poliovirus strains.
Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against viral nonstructural proteins in response to infection with poliovirus.
Ehrenfeld E; Brown D; Jia XY; Summers DF
J Infect Dis; 1995 Apr; 171(4):845-50. PubMed ID: 7535829
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
[TBL] [Abstract][Full Text] [Related]
19. The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland.
Hughes PJ; Evans DM; Minor PD; Schild GC; Almond JW; Stanway G
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2093-102. PubMed ID: 3020156
[TBL] [Abstract][Full Text] [Related]
20. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
Rombaut B; Vrijsen R; Boeyé A
J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
